Sofwave Medical reported Q2 and first-half 2026 financial results and business highlights, with revenue acceleration driven by adoption of its ultrasonic RF microneedling platform. The company continues to gain traction in the competitive RF space.
Devices & Tech
Sofwave Q2 Revenue Accelerates on Ultrasonic Demand
Ultrasonic RF microneedling platform shows strong uptake; company reports Q2 and H1 results.

1-YEAR MOVE
INMD
▲1.0%
| Ticker | Company | 1-year change |
|---|---|---|
| INMD | InMode Ltd. | +1.0% |